1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow MCI: new trials by email Literature Review of MCI trials Research Report on MCI
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effects of Methylene Blue in Healthy Aging, Mild Cognitive Impairment and Alzheimer's Disease Methylene Blue, FD&C Blue # 2, Phenazopyridine hydrochloride - Mild Cognitive Impairment, MCI | Phase 2 | Completed | The University of Texas Health Science Center at San Antonio | 117 | 2015-07-01 | 2024-09-19 |
Alzheimer Disease (1) · Cognitive Dysfunction (1)
Brain Diseases (1) · Central Nervous System Diseases (1) · Cognition Disorders (1) · Dementia (1) · Mental Disorders (1) · Nervous System Diseases (1) · Neurocognitive Disorders (1) · Neurodegenerative Diseases (1) · Tauopathies (1)
Indigo Carmine (1) · Methylene Blue (1) · Phenazopyridine (1)
The University of Texas Health Science Center at San Antonio (1)
United States (1)